Company / Shareholders' Equity
LivaNova Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.2B
FY2025
5-year range
$1.1B / $1.4B
FY2021-FY2025
Trend
-9.1%
vs FY2024
Sector context
#77 of 161
Health Care
What the data says
At $1.2B, LivaNova's shareholders' equity ranks #77 of 161 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from $1.1B in FY2022 to $1.8B in FY2017.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +1.6%.
Declined from $1.3B to $1.2B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +2.7%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
#77 of 161 in Health CareTop 48% of 161This company $1.2B Sector average $5.1B
▼
-76.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.6%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 9.1% year-over-year.
- Ranks #77 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | -9.1% |
| FY2024 | $1.3B | +3.3% |
| FY2023 | $1.3B | +15.2% |
| FY2022 | $1.1B | -19.5% |
| FY2021 | $1.4B | +24.2% |
| FY2020 | $1.1B | -19.5% |
| FY2019 | $1.4B | -8.2% |
| FY2018 | $1.5B | -17.3% |
| FY2017 | $1.8B | +6.4% |
| FY2016 | $1.7B | -5.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026